{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:04:09Z","timestamp":1793325849819,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Bacterial vaginosis is a condition associated with adverse reproductive outcomes and characterized by a shift from a\n                    <jats:italic>Lactobacillus<\/jats:italic>\n                    -dominant vaginal microbiota to a polymicrobial microbiota, consistently colonized by strains of\n                    <jats:italic>Gardnerella vaginalis<\/jats:italic>\n                    . Metronidazole is the first-line treatment; however, treatment failure and recurrence rates remain high. To understand complex interactions between\n                    <jats:italic>Gardnerella vaginalis<\/jats:italic>\n                    and\n                    <jats:italic>Lactobacillus<\/jats:italic>\n                    involved in efficacy, here we develop an ordinary differential equation model that predicts bacterial growth as a function of metronidazole uptake, sensitivity, and metabolism. The model shows that a critical factor in efficacy is\n                    <jats:italic>Lactobacillus<\/jats:italic>\n                    sequestration of metronidazole, and efficacy decreases when the relative abundance of\n                    <jats:italic>Lactobacillus<\/jats:italic>\n                    is higher pre-treatment. We validate results in\n                    <jats:italic>Gardnerella<\/jats:italic>\n                    and\n                    <jats:italic>Lactobacillus<\/jats:italic>\n                    co-cultures, and in two clinical cohorts, finding women with recurrence have significantly higher pre-treatment levels of\n                    <jats:italic>Lactobacillus<\/jats:italic>\n                    relative to bacterial vaginosis\u2013associated bacteria. Overall results provide mechanistic insight into how personalized differences in microbial communities influence vaginal antibiotic efficacy.\n                  <\/jats:p>","DOI":"10.1038\/s41467-020-19880-w","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T06:05:07Z","timestamp":1606802707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9393-2178","authenticated-orcid":false,"given":"Christina Y.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan K.","family":"Cheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1860-4550","authenticated-orcid":false,"given":"Melissa M.","family":"Lemke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8760-8320","authenticated-orcid":false,"given":"Andrew T.","family":"Gustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"France","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea R.","family":"Thurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo F.","family":"Doncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0851-2233","authenticated-orcid":false,"given":"Jacques","family":"Ravel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2968-5480","authenticated-orcid":false,"given":"Nichole R.","family":"Klatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4756-7461","authenticated-orcid":false,"given":"Kelly B.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"19880_CR1","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/OLQ.0b013e318074e565","volume":"34","author":"E Koumans","year":"2007","unstructured":"Koumans, E. et al. The prevalence of bacterial vaginosis in the United States, 2001\u20132004; associations with symptoms, sexual behaviors, and reproductive health. Sex. Transm. Dis. 34, 864\u2013869 (2007).","journal-title":"Sex. Transm. Dis."},{"key":"19880_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/OLQ.0000000000000972","volume":"46","author":"K Peebles","year":"2019","unstructured":"Peebles, K., Velloza, J., Balkus, J. E., McClelland, R. S. & Barnabas, R. V. High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex. Transm. Dis. 46, 304\u2013311 (2019).","journal-title":"Sex. Transm. Dis."},{"key":"19880_CR3","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1097\/00002030-199813000-00019","volume":"12","author":"T Taha","year":"1998","unstructured":"Taha, T. et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. Aids 12, 1699\u20131706 (1998).","journal-title":"Aids"},{"key":"19880_CR4","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1086\/423963","volume":"39","author":"CL Haggerty","year":"2004","unstructured":"Haggerty, C. L., Hillier, S. L., Bass, D. C. & Ness, R. B. Bacterial vaginosis and anaerobic bacteria are associated with endometritis. Clin. Infect. Dis. 39, 990\u2013995 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"19880_CR5","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJM199512283332604","volume":"333","author":"SL Hillier","year":"1995","unstructured":"Hillier, S. L. et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N. Engl. J. Med. 333, 1737\u20131742 (1995).","journal-title":"N. Engl. J. Med."},{"key":"19880_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1027-4","volume":"15","author":"CS Bradshaw","year":"2015","unstructured":"Bradshaw, C. S. & Brotman, R. M. Making inroads into improving treatment of bacterial vaginosis\u2014striving for long-term cure. BMC Infect. Dis. 15, 292 (2015).","journal-title":"BMC Infect. Dis."},{"key":"19880_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1093\/aje\/kwi243","volume":"162","author":"RB Ness","year":"2005","unstructured":"Ness, R. B. et al. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am. J. Epidemiol. 162, 585\u2013590 (2005).","journal-title":"Am. J. Epidemiol."},{"key":"19880_CR8","first-page":"331","volume":"89","author":"KL Nunn","year":"2016","unstructured":"Nunn, K. L. & Forney, L. J. Unraveling the dynamics of the human vaginal microbiome. Yale J. Biol. Med. 89, 331\u2013337 (2016).","journal-title":"Yale J. Biol. Med."},{"key":"19880_CR9","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1128\/JCM.01384-08","volume":"47","author":"DN Fredricks","year":"2009","unstructured":"Fredricks, D. N., Fiedler, T. L., Thomas, K. K., Mitchell, C. M. & Marrazzo, J. M. Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR. J. Clin. Microbiol. 47, 721\u2013726 (2009).","journal-title":"J. Clin. Microbiol."},{"key":"19880_CR10","doi-asserted-by":"publisher","first-page":"e10197","DOI":"10.1371\/journal.pone.0010197","volume":"5","author":"S Srinivasan","year":"2010","unstructured":"Srinivasan, S. et al. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS ONE 5, e10197 (2010).","journal-title":"PLoS ONE"},{"key":"19880_CR11","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1086\/503780","volume":"193","author":"CS Bradshaw","year":"2006","unstructured":"Bradshaw, C. S. et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J. Infect. Dis. 193, 1478\u20131486 (2006).","journal-title":"J. Infect. Dis."},{"key":"19880_CR12","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1093\/infdis\/jiw159","volume":"214","author":"CS Bradshaw","year":"2016","unstructured":"Bradshaw, C. S. & Sobel, J. D. Current treatment of bacterial vaginosis-limitations and need for innovation. J. Infect. Dis. 214, S14\u2013S20 (2016).","journal-title":"J. Infect. Dis."},{"key":"19880_CR13","doi-asserted-by":"publisher","first-page":"e019301","DOI":"10.1136\/bmjopen-2017-019301","volume":"7","author":"L Ma","year":"2017","unstructured":"Ma, L., Su, J., Su, Y., Sun, W. & Zeng, Z. Probiotics administered intravaginally as a complementary therapy combined with antibiotics for the treatment of bacterial vaginosis: a systematic review protocol. BMJ Open 7, e019301 (2017).","journal-title":"BMJ Open"},{"key":"19880_CR14","first-page":"443","volume":"41","author":"DG Ferris","year":"1995","unstructured":"Ferris, D. G., Litaker, M. S., Woodward, L., Mathis, D. & Hendrich, J. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. J. Fam. Pract. 41, 443\u2013449 (1995).","journal-title":"J. Fam. Pract."},{"key":"19880_CR15","doi-asserted-by":"crossref","unstructured":"Xiao, B. et al. Association analysis on recurrence of bacterial vaginosis revealed microbes and clinical variables important for treatment outcome. Front. Cell. Infect. Microbiol. 9, 189 (2019).","DOI":"10.3389\/fcimb.2019.00189"},{"key":"19880_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/aje\/kwn103","volume":"168","author":"RM Brotman","year":"2008","unstructured":"Brotman, R. M. et al. A longitudinal study of vaginal douching and bacterial vaginosis\u2014a marginal structural modeling analysis. Am. J. Epidemiol. 168, 188\u2013196 (2008).","journal-title":"Am. J. Epidemiol."},{"key":"19880_CR17","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s10096-014-2128-5","volume":"33","author":"B Wang","year":"2014","unstructured":"Wang, B. et al. Molecular analysis of the relationship between specific vaginal bacteria and bacterial vaginosis metronidazole therapy failure. Eur. J. Clin. Microbiol. Infect. Dis. 33, 1749\u20131756 (2014).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"19880_CR18","doi-asserted-by":"crossref","unstructured":"Zhou, X. et al. Recent advances in understanding the microbiology of the female reproductive tract and the causes of premature birth. Infect. Dis. Obstet. Gynecol. https:\/\/www.hindawi.com\/journals\/idog\/2010\/737425\/abs\/ (2010).","DOI":"10.1155\/2010\/737425"},{"key":"19880_CR19","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1099\/jmm.0.000561","volume":"66","author":"CST Ferreira","year":"2017","unstructured":"Ferreira, C. S. T. et al. Treatment failure of bacterial vaginosis is not associated with higher loads of Atopobium vaginae and Gardnerella vaginalis. J. Med. Microbiol. 66, 1217\u20131224 (2017).","journal-title":"J. Med. Microbiol."},{"key":"19880_CR20","doi-asserted-by":"crossref","unstructured":"Coleman, J. S. & Gaydos, C. A. Molecular diagnosis of bacterial vaginosis: an update. J. Clin. Microbiol. 56, e00342-18 (2018).","DOI":"10.1128\/JCM.00342-18"},{"key":"19880_CR21","doi-asserted-by":"publisher","first-page":"132ra52","DOI":"10.1126\/scitranslmed.3003605","volume":"4","author":"P Gajer","year":"2012","unstructured":"Gajer, P. et al. Temporal dynamics of the human vaginal microbiota. Sci. Transl. Med. 4, 132ra52 (2012).","journal-title":"Sci. Transl. Med."},{"key":"19880_CR22","doi-asserted-by":"publisher","unstructured":"Tamarelle, J. et al. Non-optimal vaginal microbiota after azithromycin treatment for Chlamydia trachomatis infection. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiz499 (2019).","DOI":"10.1093\/infdis\/jiz499"},{"key":"19880_CR23","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.resmic.2017.09.003","volume":"168","author":"M Vaneechoutte","year":"2017","unstructured":"Vaneechoutte, M. Lactobacillus iners, the unusual suspect. Res. Microbiol. 168, 826\u2013836 (2017).","journal-title":"Res. Microbiol."},{"key":"19880_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.mib.2015.04.004","volume":"25","author":"K Faust","year":"2015","unstructured":"Faust, K., Lahti, L., Gonze, D., de Vos, W. M. & Raes, J. Metagenomics meets time series analysis: unraveling microbial community dynamics. Curr. Opin. Microbiol. 25, 56\u201366 (2015).","journal-title":"Curr. Opin. Microbiol."},{"key":"19880_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-019-0660-3","volume":"7","author":"J Lugo-Martinez","year":"2019","unstructured":"Lugo-Martinez, J., Ruiz-Perez, D., Narasimhan, G. & Bar-Joseph, Z. Dynamic interaction network inference from longitudinal microbiome data. Microbiome 7, 54 (2019).","journal-title":"Microbiome"},{"key":"19880_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/sti.2009.040592","volume":"86","author":"RM Brotman","year":"2010","unstructured":"Brotman, R. M., Ravel, J., Cone, R. A. & Zenilman, J. M. Rapid fluctuation of the vaginal microbiota measured by Gram stain analysis. Sex. Transm. Infect. 86, 297\u2013302 (2010).","journal-title":"Sex. Transm. Infect."},{"key":"19880_CR27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1128\/AAC.13.3.460","volume":"13","author":"FP Tally","year":"1978","unstructured":"Tally, F. P., Goldin, B. R., Sullivan, N., Johnston, J. & Gorbach, S. L. Antimicrobial activity of metronidazole in anaerobic bacteria. Antimicrob. Agents Chemother. 13, 460\u2013465 (1978).","journal-title":"Antimicrob. Agents Chemother."},{"key":"19880_CR28","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/0006-2952(88)90014-7","volume":"37","author":"DL Church","year":"1988","unstructured":"Church, D. L., Rabin, H. R. & Lalshley, E. J. Role of hydrogenase 1 of clostridium pasteurianum in the reduction of metronidazole. Biochem. Pharmacol. 37, 1525\u20131534 (1988).","journal-title":"Biochem. Pharmacol."},{"key":"19880_CR29","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1126\/science.aai9383","volume":"356","author":"NR Klatt","year":"2017","unstructured":"Klatt, N. R. et al. Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women. Science 356, 938\u2013945 (2017).","journal-title":"Science"},{"key":"19880_CR30","first-page":"285","volume":"56","author":"DI Edwards","year":"1980","unstructured":"Edwards, D. I. Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs. Br. J. Vener. Dis. 56, 285\u2013290 (1980).","journal-title":"Br. J. Vener. Dis."},{"key":"19880_CR31","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1128\/AAC.14.3.377","volume":"14","author":"ED Ralph","year":"1978","unstructured":"Ralph, E. D. & Clarke, D. A. Inactivation of metronidazole by anaerobic and aerobic bacteria. Antimicrob. Agents Chemother. 14, 377\u2013383 (1978).","journal-title":"Antimicrob. Agents Chemother."},{"key":"19880_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/jac\/5.3.315","volume":"5","author":"DI Edwards","year":"1979","unstructured":"Edwards, D. I., Thompson, E. J., Tomusange, J. & Shanson, D. Inactivation of metronidazole by aerobic organisms. J. Antimicrob. Chemother. 5, 315\u2013316 (1979).","journal-title":"J. Antimicrob. Chemother."},{"key":"19880_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/2049-2618-1-29","volume":"1","author":"J Ravel","year":"2013","unstructured":"Ravel, J. et al. Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis. Microbiome 1, 29 (2013).","journal-title":"Microbiome"},{"key":"19880_CR34","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1089\/aid.2015.0006","volume":"31","author":"AR Thurman","year":"2015","unstructured":"Thurman, A. R. et al. Bacterial vaginosis and subclinical markers of genital tract inflammation and mucosal immunity. AIDS Res. Hum. Retroviruses 31, 1139\u20131152 (2015).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"19880_CR35","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1016\/0006-2952(79)90407-6","volume":"28","author":"RL Koch","year":"1979","unstructured":"Koch, R. L., Chrystal, E. J., Beaulieu, B. B. & Goldman, P. Acetamide\u2014a metabolite of metronidazole formed by the intestinal flora. Biochem. Pharmacol. 28, 3611\u20133615 (1979).","journal-title":"Biochem. Pharmacol."},{"key":"19880_CR36","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1128\/AAC.48.10.3670-3676.2004","volume":"48","author":"RR Regoes","year":"2004","unstructured":"Regoes, R. R. et al. Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens. Antimicrob. Agents Chemother. 48, 3670\u20133676 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"19880_CR37","doi-asserted-by":"publisher","first-page":"eaau1873","DOI":"10.1126\/sciadv.aau1873","volume":"4","author":"HR Meredith","year":"2018","unstructured":"Meredith, H. R. et al. Applying ecological resistance and resilience to dissect bacterial antibiotic responses. Sci. Adv. 4, eaau1873 (2018).","journal-title":"Sci. Adv."},{"key":"19880_CR38","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/0006-2952(74)90362-1","volume":"23","author":"RM Ings","year":"1974","unstructured":"Ings, R. M., McFadzean, J. A. & Ormerod, W. E. The mode of action of metronidazole in Trichomonas vaginalis and other micro-organisms. Biochem. Pharmacol. 23, 1421\u20131429 (1974).","journal-title":"Biochem. Pharmacol."},{"key":"19880_CR39","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/0002-9378(84)90130-3","volume":"149","author":"B Davis","year":"1984","unstructured":"Davis, B., Glover, D. D. & Larsen, B. Analysis of metronidazole penetration into vaginal fluid by reversed-phase high-performance liquid chromatography. Am. J. Obstet. Gynecol. 149, 802\u2013803 (1984).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"19880_CR40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1086\/321002","volume":"184","author":"JA Simoes","year":"2001","unstructured":"Simoes, J. A. et al. Human immunodeficiency virus type 1 stimulatory activity by Gardnerella vaginalis: relationship to biotypes and other pathogenic characteristics. J. Infect. Dis. 184, 22\u201327 (2001).","journal-title":"J. Infect. Dis."},{"key":"19880_CR41","doi-asserted-by":"crossref","unstructured":"Brooks, J. P. et al. Changes in vaginal community state types reflect major shifts in the microbiome. Microb. Ecol. Health Dis. 28, 1303265 (2017).","DOI":"10.1080\/16512235.2017.1303265"},{"key":"19880_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1155\/S1064744901000072","volume":"9","author":"JA Simoes","year":"2001","unstructured":"Simoes, J. A., Aroutcheva, A. A., Shott, S. & Faro, S. Effect of metronidazole on the growth of vaginal lactobacilli in vitro. Infect. Dis. Obstet. Gynecol. 9, 41\u201345 (2001).","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"19880_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-6-51","volume":"6","author":"E De Backer","year":"2006","unstructured":"De Backer, E. et al. Antibiotic susceptibility of Atopobium vaginae. BMC Infect. Dis. 6, 51 (2006).","journal-title":"BMC Infect. Dis."},{"key":"19880_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.anaerobe.2017.05.005","volume":"47","author":"MAB Petrina","year":"2017","unstructured":"Petrina, M. A. B., Cosentino, L. A., Rabe, L. K. & Hillier, S. L. Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin. Anaerobe 47, 115\u2013119 (2017).","journal-title":"Anaerobe"},{"key":"19880_CR45","first-page":"48","volume":"20","author":"KC Anukam","year":"2008","unstructured":"Anukam, K. C. & Reid, G. Effects of metronidazole on growth of Gardnerella vaginalis ATCC 14018, probiotic Lactobacillus rhamnosus GR-1 and vaginal isolate Lactobacillus plantarum KCA. Microb. Ecol. Health Dis. 20, 48\u201352 (2008).","journal-title":"Microb. Ecol. Health Dis."},{"key":"19880_CR46","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1128\/IAI.05496-11","volume":"80","author":"CG Buffie","year":"2012","unstructured":"Buffie, C. G. et al. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to clostridium difficile-induced colitis. Infect. Immun. 80, 62\u201373 (2012).","journal-title":"Infect. Immun."},{"key":"19880_CR47","doi-asserted-by":"publisher","first-page":"7063","DOI":"10.1128\/AEM.02385-16","volume":"82","author":"MT France","year":"2016","unstructured":"France, M. T., Mendes-Soares, H. & Forney, L. J. Genomic comparisons of Lactobacillus crispatus and Lactobacillus iners reveal potential ecological drivers of community composition in the vagina. Appl. Environ. Microbiol. 82, 7063\u20137073 (2016).","journal-title":"Appl. Environ. Microbiol."},{"key":"19880_CR48","doi-asserted-by":"publisher","first-page":"e80074","DOI":"10.1371\/journal.pone.0080074","volume":"8","author":"DE O\u2019Hanlon","year":"2013","unstructured":"O\u2019Hanlon, D. E., Moench, T. R. & Cone, R. A. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS ONE 8, e80074 (2013).","journal-title":"PLoS ONE"},{"key":"19880_CR49","doi-asserted-by":"crossref","unstructured":"Atassi, F., Pho Viet Ahn, D. L. & Lievin-Le Moal, V. Diverse expression of antimicrobial activities against bacterial vaginosis and urinary tract infection pathogens by cervicovaginal microbiota strains of Lactobacillus gasseri and Lactobacillus crispatus. Front. Microbiol. 10, 2900 (2019).","DOI":"10.3389\/fmicb.2019.02900"},{"key":"19880_CR50","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1574-695X.2006.00162.x","volume":"48","author":"F Atassi","year":"2006","unstructured":"Atassi, F., Brassart, D., Grob, P., Graf, F. & Servin, A. L. Lactobacillus strains isolated from the vaginal microbiota of healthy women inhibit Prevotella bivia and Gardnerella vaginalis in coculture and cell culture. FEMS Immunol. Med. Microbiol. 48, 424\u2013432 (2006).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"19880_CR51","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/infdis\/175.2.406","volume":"175","author":"V Pybus","year":"1997","unstructured":"Pybus, V. & Onderdonk, A. B. Evidence for a commensal, symbiotic relationship between Gardnerella vaginalis and Prevotella bivia involving ammonia: potential significance for bacterial vaginosis. J. Infect. Dis. 175, 406\u2013413 (1997).","journal-title":"J. Infect. Dis."},{"key":"19880_CR52","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1073\/pnas.1002611107","volume":"108","author":"J Ravel","year":"2011","unstructured":"Ravel, J. et al. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. USA 108, 4680\u20134687 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"19880_CR53","doi-asserted-by":"publisher","unstructured":"Deng, Z.-L. et al. Metatranscriptome analysis of the vaginal microbiota reveals potential mechanisms for protection against metronidazole in bacterial vaginosis. mSphere 3, https:\/\/doi.org\/10.1128\/mSphereDirect.00262-18 (2018).","DOI":"10.1128\/mSphereDirect.00262-18"},{"key":"19880_CR54","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/clinids\/11.3.361","volume":"11","author":"I Brook","year":"1989","unstructured":"Brook, I. Inoculum effect. Rev. Infect. Dis. 11, 361\u2013368 (1989).","journal-title":"Rev. Infect. Dis."},{"key":"19880_CR55","doi-asserted-by":"crossref","unstructured":"Xiao, B. et al. Predictive value of the composition of the vaginal microbiota in bacterial vaginosis, a dynamic study to identify recurrence-related flora. Sci. Rep. 6, 26674 (2016).","DOI":"10.1038\/srep26674"},{"key":"19880_CR56","doi-asserted-by":"publisher","first-page":"157.e1","DOI":"10.1016\/j.ajog.2019.08.008","volume":"222","author":"MC Verwijs","year":"2020","unstructured":"Verwijs, M. C., Agaba, S. K., Darby, A. C. & Wijgert, J. H. H. Mvande Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure. Am. J. Obstet. Gynecol. 222, 157.e1\u2013157.e13 (2020).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"19880_CR57","unstructured":"Allee, W. C. Principles of Animal Ecology (Saunders Co., 1949)."},{"key":"19880_CR58","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00203-016-1323-4","volume":"199","author":"M Goswami","year":"2017","unstructured":"Goswami, M., Bhattacharyya, P. & Tribedi, P. Allee effect: the story behind the stabilization or extinction of microbial ecosystem. Arch. Microbiol. 199, 185\u2013190 (2017).","journal-title":"Arch. Microbiol."},{"key":"19880_CR59","doi-asserted-by":"publisher","first-page":"e1003388","DOI":"10.1371\/journal.pcbi.1003388","volume":"9","author":"RR Stein","year":"2013","unstructured":"Stein, R. R. et al. Ecological modeling from time-series inference: insight into dynamics and stability of intestinal microbiota. PLoS Comput. Biol. 9, e1003388 (2013).","journal-title":"PLoS Comput. Biol."},{"key":"19880_CR60","doi-asserted-by":"crossref","unstructured":"May, R. Stability and Complexity in Model Ecosystems (2001).","DOI":"10.1515\/9780691206912"},{"key":"19880_CR61","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cels.2018.08.003","volume":"7","author":"GL Medlock","year":"2018","unstructured":"Medlock, G. L. et al. Inferring metabolic mechanisms of interaction within a defined gut microbiota. Cell Syst. 7, 245\u2013257 (2018).","journal-title":"Cell Syst."},{"key":"19880_CR62","doi-asserted-by":"publisher","first-page":"e25051","DOI":"10.7554\/eLife.25051","volume":"6","author":"B Momeni","year":"2017","unstructured":"Momeni, B., Xie, L. & Shou, W. Lotka-Volterra pairwise modeling fails to capture diverse pairwise microbial interactions. eLife 6, e25051 (2017).","journal-title":"eLife"},{"key":"19880_CR63","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1126\/science.aat1168","volume":"361","author":"JE Goldford","year":"2018","unstructured":"Goldford, J. E. et al. Emergent simplicity in microbial community assembly. Science 361, 469\u2013474 (2018).","journal-title":"Science"},{"key":"19880_CR64","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1017\/S0370164600025426","volume":"31","author":"AG McKendrick","year":"1912","unstructured":"McKendrick, A. G. & Pai, M. K. XLV.\u2014The rate of multiplication of micro-organisms: a mathematical study. Proc. R. Soc. Edinb. 31, 649\u2013653 (1912).","journal-title":"Proc. R. Soc. Edinb."},{"key":"19880_CR65","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jtbi.2008.04.011","volume":"254","author":"S Marino","year":"2008","unstructured":"Marino, S., Hogue, I. B., Ray, C. J. & Kirschner, D. E. A methodology for performing global uncertainty and sensitivity analysis in systems biology. J. Theor. Biol. 254, 178\u2013196 (2008).","journal-title":"J. Theor. Biol."},{"key":"19880_CR66","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/jac\/18.5.565","volume":"18","author":"S Narikawa","year":"1986","unstructured":"Narikawa, S. Distribution of metronidazole susceptibility factors in obligate anaerobes. J. Antimicrob. Chemother. 18, 565\u2013574 (1986).","journal-title":"J. Antimicrob. Chemother."},{"key":"19880_CR67","doi-asserted-by":"publisher","first-page":"10457","DOI":"10.1021\/jf9024135","volume":"57","author":"H Guill\u00e9n","year":"2009","unstructured":"Guill\u00e9n, H., Curiel, J. A., Landete, J. M., Mu\u00f1oz, R. & Herraiz, T. Characterization of a nitroreductase with selective nitroreduction properties in the food and intestinal lactic acid bacterium Lactobacillus plantarum WCFS1. J. Agric. Food Chem. 57, 10457\u201310465 (2009).","journal-title":"J. Agric. Food Chem."},{"key":"19880_CR68","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0968-0004(98)01298-5","volume":"23","author":"SF Altschul","year":"1998","unstructured":"Altschul, S. F. & Koonin, E. V. Iterated profile searches with PSI-BLAST\u2014a tool for discovery in protein databases. Trends Biochem. Sci. 23, 444\u2013447 (1998).","journal-title":"Trends Biochem. Sci."},{"key":"19880_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-38253-4","volume":"9","author":"E Chetwin","year":"2019","unstructured":"Chetwin, E. et al. Antimicrobial and inflammatory properties of South African clinical Lactobacillus isolates and vaginal probiotics. Sci. Rep. 9, 1917 (2019).","journal-title":"Sci. Rep."},{"key":"19880_CR70","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1099\/jmm.0.05155-0","volume":"52","author":"MS Ju\u00e1rez Tom\u00e1s","year":"2003","unstructured":"Ju\u00e1rez Tom\u00e1s, M. S., Oca\u00f1a, V. S., Wiese, B. & Nader-Mac\u00edas, M. E. Growth and lactic acid production by vaginal Lactobacillus acidophilus CRL 1259, and inhibition of uropathogenic Escherichia coli. J. Med. Microbiol. 52, 1117\u20131124 (2003).","journal-title":"J. Med. Microbiol."},{"key":"19880_CR71","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fcimb.2020.00083","volume":"10","author":"J Castro","year":"2020","unstructured":"Castro, J., Rosca, A. S., Cools, P., Vaneechoutte, M. & Cerca, N. Gardnerella vaginalis enhances Atopobium vaginae viability in an in vitro model. Front. Cell. Infect. Microbiol. 10, 83 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"19880_CR72","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1242\/jeb.12.1.44","volume":"12","author":"GF Gause","year":"1935","unstructured":"Gause, G. F. Experimental demonstration of Volterra\u2019s periodic oscillations in the numbers of animals. J. Exp. Biol. 12, 44\u201348 (1935).","journal-title":"J. Exp. Biol."},{"key":"19880_CR73","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/intbio\/zyz006","volume":"11","author":"CM Jackman","year":"2019","unstructured":"Jackman, C. M., Deans, K. W., Forney, L. J. & Lin, X. N. Microdroplet co-cultivation and interaction characterization of human vaginal bacteria. Integr. Biol. 11, 69\u201378 (2019).","journal-title":"Integr. Biol."},{"key":"19880_CR74","doi-asserted-by":"publisher","first-page":"7063","DOI":"10.1128\/AEM.02385-16","volume":"82","author":"MT France","year":"2016","unstructured":"France, M. T., Mendes-Soares, H. & Forney, L. J. Genomic comparisons of Lactobacillus crispatus and Lactobacillus iners reveal potential ecological drivers of community composition in the vagina. Appl. Environ. Microbiol. 82, 7063\u20137073 (2016).","journal-title":"Appl. Environ. Microbiol."},{"key":"19880_CR75","unstructured":"CDC - STD Treatment. https:\/\/www.cdc.gov\/std\/treatment\/default.htm (2020)."},{"key":"19880_CR76","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1089\/aid.2018.0304","volume":"35","author":"LR McKinnon","year":"2019","unstructured":"McKinnon, L. R. et al. The evolving facets of bacterial vaginosis: implications for HIV transmission. AIDS Res. Hum. Retroviruses 35, 219\u2013228 (2019).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"19880_CR77","doi-asserted-by":"publisher","unstructured":"Lee, C. Y. et al. Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis, chyylee\/BV, https:\/\/doi.org\/10.5281\/zenodo.4121904 (2020).","DOI":"10.5281\/zenodo.4121904"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19880-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19880-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19880-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T20:53:34Z","timestamp":1670273614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19880-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["19880"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-19880-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-66397\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,1]]},"assertion":[{"value":"26 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.R. is co-founder of LUCA Biologics, a biotechnology company focusing on translating microbiome research into live biotherapeutic drugs for women\u2019s health. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6147"}}